Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Cara Therapeutics Inc (CARA)
Cara Therapeutics Inc (CARA) Financials

CARA Cara Therapeutics Inc

0.27

-0.0002 (-0.07%)

13 Sep 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-65.566	-72.28	-51.429	-50.202	3.337	-34.133	-39.821	-76.936
Return on Equity (%)	-73.545	-84.542	-67.159	-66.412	3.86	-37.119	-44.253	-109.803
Return on Invested Capital (%)	-74.334	-85.14	-77.165	-94.363	4.035	-53.122	-57.44	-119.691
Operating Margin (%)	-67148.837	-6402.744	-552.394	-539.017	5.714	-384.059	-204.156	-562.328
Net Profit Margin (%)	-66604.651	-6380.351	-549.506	-534.914	6.226	-384.059	-204.156	-565.209
Book Value Per Share	1.858	2.657	3.379	3.996	4.993	4.254	2.951	1.048
Earnings Per Share	-2.098	-1.78	-1.871	-2.277	0.169	-1.654	-1.589	-2.175
Cash Per Share	0.443	0.287	0.381	0.392	0.635	0.252	1.185	0.95
Working Capital Per Share	1.828	2.65	3.229	2.628	3.541	2.911	2.704	1.662
Operating Profit Per Share	0.003	0.028	0.341	0.426	2.709	0.431	0.648	0.272
EBIT Per Share	-2.116	-1.786	-1.881	-2.294	0.155	-1.654	-1.589	-2.175
EBITDA Per Share	-2.116	-1.786	-1.881	-2.294	0.155	-1.654	-1.589	-2.175
Free Cash Flow Per Share	-2.126	-1.793	-1.879	-2.281	0.171	-1.658	-1.593	-2.136

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	27.3M	32.66M	39.55M	46.72M	49.87M	53.48M	53.8M	N/A

Key Stats and Ratios

Year End 31 December 2023	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	53.71M	53.73M	53.8M	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-432.522	N/A	N/A	N/A	-1344.918
Net Profit Margin (%)	N/A	N/A	N/A	-432.522	N/A	N/A	N/A	-1437.752
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	14.82M
Price to Earnings Ratio	-0.12
Price to Sales Ratio	0.68
Price to Cash Ratio	0.28
Price to Book Ratio	0.25
Dividend Yield	-

Share Statistics

Shares Outstanding	54.85M
Average Volume (1 week)	372.73k
Average Volume (1 Month)	684.31k
52 Week Change	-98.23%
52 Week High	18.93
52 Week Low	0.24

More Ratios Coming Soon!

Cara Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions